Isaiah C Lugtu1,2, Wen-Han Cheng1,3, Shih-Lin Chang1,3, Shin-Huei Liu1,3, Li-Wei Lo1,3, Shih-Ann Chen1,3,4. 1. Heart Rhythm Center and Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan. 2. Heart Institute, Chinese General Hospital and Medical Center, Metro Manila, Philippines. 3. Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang Ming Chiao Tung University, Taipei. 4. Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
Abstract
Background: Left atrial appendage (LAA) is the main source of thrombus formation, and occlusion of this structure decreases the risk of stroke in patients with atrial fibrillation. Objectives: We aimed to describe the feasibility, safety and outcomes of percutaneous LAA closure using an occluder device, and to evaluate residual LAA contrast leak detected on computed tomography (CT) imaging in patients who underwent implantation in our institution. Methods: Consecutive patients of Taipei Veterans General Hospital who underwent percutaneous implantation of an LAA occluder (LAAO) were retrospectively collected and analyzed. Results: A total of 23 patients were included with a median age of 67 years (42-87) and median CHA2DS2-VASc score of 4 (1-7). The most frequent indication for intervention was bleeding while on oral anticoagulation treatment. After a mean follow-up of 31.17 ± 25.10 months, successful device implantation was achieved in 95.7% of the patients. There was no occurrence of death, stroke, device embolization, acute ST elevation myocardial infarction, major bleeding requiring invasive treatment or blood transfusion, inguinal hematoma or major bleeding related to antiplatelet therapy. One patient had cardiac tamponade, 1 had intra-procedural thrombus formation, 1 had impingement of mitral valve leaflet, and 1 had device-related thrombosis. Of 12 patients who underwent CT post- implantation, 6 had residual contrast leak into the LAA, one third of those who had peri-device leak. Conclusions: Percutaneous implantation of an LAAO appeared to be feasible with a low risk of major complications.
Background: Left atrial appendage (LAA) is the main source of thrombus formation, and occlusion of this structure decreases the risk of stroke in patients with atrial fibrillation. Objectives: We aimed to describe the feasibility, safety and outcomes of percutaneous LAA closure using an occluder device, and to evaluate residual LAA contrast leak detected on computed tomography (CT) imaging in patients who underwent implantation in our institution. Methods: Consecutive patients of Taipei Veterans General Hospital who underwent percutaneous implantation of an LAA occluder (LAAO) were retrospectively collected and analyzed. Results: A total of 23 patients were included with a median age of 67 years (42-87) and median CHA2DS2-VASc score of 4 (1-7). The most frequent indication for intervention was bleeding while on oral anticoagulation treatment. After a mean follow-up of 31.17 ± 25.10 months, successful device implantation was achieved in 95.7% of the patients. There was no occurrence of death, stroke, device embolization, acute ST elevation myocardial infarction, major bleeding requiring invasive treatment or blood transfusion, inguinal hematoma or major bleeding related to antiplatelet therapy. One patient had cardiac tamponade, 1 had intra-procedural thrombus formation, 1 had impingement of mitral valve leaflet, and 1 had device-related thrombosis. Of 12 patients who underwent CT post- implantation, 6 had residual contrast leak into the LAA, one third of those who had peri-device leak. Conclusions: Percutaneous implantation of an LAAO appeared to be feasible with a low risk of major complications.
Entities:
Keywords:
Contrast leak; Left atrial appendage; Occluder device
Authors: Benjamin A Steinberg; Melissa A Greiner; Bradley G Hammill; Lesley H Curtis; Emelia J Benjamin; Susan R Heckbert; Jonathan P Piccini Journal: Cardiovasc Ther Date: 2015-08 Impact factor: 3.023
Authors: Jan Steffel; Ronan Collins; Matthias Antz; Pieter Cornu; Lien Desteghe; Karl Georg Haeusler; Jonas Oldgren; Holger Reinecke; Vanessa Roldan-Schilling; Nigel Rowell; Peter Sinnaeve; Thomas Vanassche; Tatjana Potpara; A John Camm; Hein Heidbüchel; Gregory Y H Lip; Thomas Deneke; Nikolaos Dagres; Giuseppe Boriani; Tze-Fan Chao; Eue-Keun Choi; Mellanie True Hills; Itamar de Souza Santos; Deirdre A Lane; Dan Atar; Boyoung Joung; Oana Maria Cole; Mark Field Journal: Europace Date: 2021-04-25 Impact factor: 5.214
Authors: Srinivas R Dukkipati; Saibal Kar; David R Holmes; Shephal K Doshi; Vijendra Swarup; Douglas N Gibson; Brijeshwar Maini; Nicole T Gordon; Michael L Main; Vivek Y Reddy Journal: Circulation Date: 2018-08-28 Impact factor: 29.690
Authors: David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick Journal: Lancet Date: 2009-08-15 Impact factor: 79.321
Authors: Marina Urena; Josep Rodés-Cabau; Xavier Freixa; Jacqueline Saw; John G Webb; Mélanie Freeman; Eric Horlick; Mark Osten; Albert Chan; Jean-Francois Marquis; Jean Champagne; Réda Ibrahim Journal: J Am Coll Cardiol Date: 2013-05-09 Impact factor: 24.094
Authors: Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins Journal: Eur Heart J Date: 2021-02-01 Impact factor: 29.983